| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/28/2007 | CN1301749C Polyepitope DNA vaccine of anti-simple herpes virus-2 infection and its preparing method |
| 02/28/2007 | CN1301742C Chinese medical preparation for preventing and curing blaze of shrimps corpus hemorrhagicum, gill rot and pond syndrome |
| 02/28/2007 | CN1301722C Sow thistle extract, preparing process and application thereof |
| 02/28/2007 | CN1301717C Inclusion compound of glycyrrhizic acid or its derivative and alkaloid, and its preparation method |
| 02/28/2007 | CN1301711C Use of vegetable flavonoid |
| 02/27/2007 | US7183440 Pharmaceutically useful compounds |
| 02/27/2007 | US7183412 Ester or amide derivatives |
| 02/27/2007 | US7183404 Infectious salmon anaemia (ISA); genetic vaccine comprising cDNA coding for immunogenic proteins from ISA virus; ISA is a viral disease that affects Atlantic salmon in cultivation |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183301 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 02/27/2007 | US7183284 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183268 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183111 Immunomodulatory formulations and methods for use thereof |
| 02/27/2007 | US7183095 Cell culture system for synthesis of infectious hepatitis C virus |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7182965 pollen polyterpenes for the treatment of microbial, especially bacterial, diseases for topical, oral and parenteral administration in humans and animals |
| 02/27/2007 | US7182953 Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| 02/22/2007 | WO2007022520A2 Antibody-mediated enhancement of immune response |
| 02/22/2007 | WO2007022511A2 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 02/22/2007 | WO2007021721A2 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| 02/22/2007 | WO2007021164A1 Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium |
| 02/22/2007 | WO2007020936A1 Bicyclo heterocyclic compound having antifungal action |
| 02/22/2007 | WO2007020935A1 Therapeutic agent for pain comprising p2y12 receptor and/or p2y14 receptor blocker |
| 02/22/2007 | WO2007020889A1 Novel mucin glycoprotein and use thereof |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020884A1 BIFIDOBACTERIUM OR LACTIC ACID BACTERIUM HAVING EFFECT OF PREVENTING INFECTION VIA β-DEFENSIN AND FOOD/PHARMACEUTICAL COMPOSITION CONTAINING THE SAME |
| 02/22/2007 | WO2007020873A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 02/22/2007 | WO2007020478A1 Virucidal solutions |
| 02/22/2007 | WO2007020426A1 Pyrazolone derivatives for the treatment of tuberculosis |
| 02/22/2007 | WO2007019674A1 Viral polymerase inhibitors |
| 02/22/2007 | WO2006135763A3 Inhibitors of dna repair enzymes and methods of use thereof |
| 02/22/2007 | WO2006127217A3 Cyclopropanecarboxylate esters of acyclovir |
| 02/22/2007 | WO2006120252A3 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 02/22/2007 | WO2006086321A3 Antimicrobial hexapeptides |
| 02/22/2007 | WO2006076015A3 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof |
| 02/22/2007 | WO2006059169A3 Antiviral and immunostimulating marine fish oil composition |
| 02/22/2007 | WO2006019841A3 Treatment of viral infections with egr 1 activators |
| 02/22/2007 | WO2005120516A3 Hiv integrase inhibitors |
| 02/22/2007 | WO2004098491A3 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043073 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 02/22/2007 | US20070043070 Weak base salts |
| 02/22/2007 | US20070043040 Inhibitors of akt (protein kinase b) |
| 02/22/2007 | US20070042995 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria |
| 02/22/2007 | US20070042990 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/22/2007 | US20070042974 Nozel azalide and azalactam derivatives and method for producing the same |
| 02/22/2007 | US20070042967 Proteaseome inhibitors for the treatment of herpesviridae infected individuals |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042353 HCV polymerase suitable for crystal structure analysis and method for using the enzyme |
| 02/22/2007 | US20070042000 Porcine reproductive and respiratory syndrome vaccine based on isolate ja-142 |
| 02/22/2007 | US20070041998 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 02/22/2007 | US20070041995 Oral compositions for HIV-infected subjects |
| 02/22/2007 | US20070041976 Treating septic arthritis; Interleukin-4 (IL-4), previously known as B cell stimulating factor |
| 02/22/2007 | US20070041956 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2007 | US20070041938 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 02/22/2007 | US20070041866 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | DE102005038768A1 Pharmaceutical active substance for the treatment of hepatitis A, hepatitis C, borrelia and/or multiple sclerosis, comprises an unpurified gland secretion obtained from animals of the class Diplopoda |
| 02/22/2007 | DE102005037096A1 Medicament, useful to treat or prevent e.g. viral infections, comprises a combination of iron-oxide, ferric oxide hydrate, magnetite and/or hematite and a lanthanide compound |
| 02/22/2007 | CA2619262A1 Pyrazolone derivatives for the treatment of tuberculosis |
| 02/22/2007 | CA2618791A1 Novel mucin-type glycoprotein and use thereof |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618638A1 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| 02/21/2007 | EP1754714A1 cyclic peptide derivatives as inhibitors of integrin alpha v beta 6 |
| 02/21/2007 | EP1754710A2 2'-Fluoroncucleosides |
| 02/21/2007 | EP1754477A2 Hydroxamic acid derivatives as antibacterials |
| 02/21/2007 | EP1754472A2 Compositions for treatment of disorders associated with chlamydia |
| 02/21/2007 | EP1753858A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 02/21/2007 | EP1753756A1 3-¬4-(6-{4,5-dihydroisoxazol-3-yl}pyridin-3-yl)-3-phenyl|-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents |
| 02/21/2007 | EP1753755A1 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents |
| 02/21/2007 | EP1753754A1 3- '4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents |
| 02/21/2007 | EP1753753A1 3-(4-(2-dihydroisoxazol-3-ylpyrdin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections |
| 02/21/2007 | EP1753736A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
| 02/21/2007 | EP1753712A1 Amino-propanol derivatives |
| 02/21/2007 | EP1753427A1 Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
| 02/21/2007 | EP1529047B1 New purine derivatives |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1463513B1 Stabilized brivudine topical formulations |
| 02/21/2007 | EP1458725B1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| 02/21/2007 | EP1438066B1 Incapacitated whole-cell immunogenic bacterial compositions |
| 02/21/2007 | EP1414316B1 Nutritional composition preventing bacterial overgrowth |
| 02/21/2007 | EP1389466B1 A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1290006B1 Combinatorial production of nucleotide and nucleoside (XITP) analogues |
| 02/21/2007 | EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |